ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,025.99
      -0.95%
      US Tech 100
      20,874.00
      -1.46%
      Dow Jones
      44,303.40
      -0.99%
      Brent Oil
      74.565
      0.00%
      Bitcoin
      97,094.37
      0.66%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Poxel (POXEL) Quote

      Poxel

      Poxel (POXEL)

      EU
      0.273
      -0.007
      (-2.50%)
      Closed February 09 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.273
      Bid
      0.27
      Ask
      0.273
      Volume
      276,087
      0.26 Day's Range 0.285
      0.115 52 Week Range 0.898
      Market Cap
      12.718M
      Previous Close
      0.28
      Open
      0.285
      Last Trade
      1358
      @
      0.273
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      717,799
      Shares Outstanding
      46,586,753
      Dividend Yield
      -
      PE Ratio
      -0.36
      Earnings Per Share (EPS)
      -0.75
      Revenue
      1.98M
      Net Profit
      -35.09M

      About Poxel

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.poxelpharma.com
      Headquarters
      Lyon, Rhone, Fra
      Founded
      -
      Poxel is listed in the Pharmaceutical Preparations sector of the Euronext with ticker POXEL. The last closing price for Poxel was 0.28 €. Over the last year, Poxel shares have traded in a share price range of 0.115 € to 0.898 €.

      Poxel currently has 46,586,753 shares outstanding. The market capitalization of Poxel is 13.04 € million. Poxel has a price to earnings ratio (PE ratio) of -0.36.

      Ask ADVFN Intelligence (AI)

      POXEL Latest News

      More News

      Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast

      TWYMEEG® sales continued to increase in Japan for the last quarter 2024 (October-December) by 17% over the prior quarter and by 154% over Q4 2023 TWYMEEG®’s FY 20241 revised forecast2 of JPY 7.9...

      January 31 2025
      Business Wire

      Poxel annonce son agenda financier pour l’exercice 2025

      Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société biopharmaceutique au stade clinique développant des traitements innovants pour les maladies chroniques graves à...

      January 23 2025
      Business Wire

      Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025

      Poxel announces that a Combined General Meeting will be held on February 11, 2025, at 9:00 a.m. CET and the availability of the preparatory documents Poxel announces the addition of a new...

      January 21 2025
      Business Wire

      Poxel annonce la délivrance d’un brevet en Chine protégeant l’utilisation de l’Imeglimine chez les patients diabétiques de type 2 atteints d’insuffisance rénale

      Durée de vie des brevets couvrant l’Imeglimine en Chine étendue jusqu’en 2039 Poursuite des discussions en vue d’un partenariat pour le développement et la commercialisation de l’Imeglimine en...

      January 20 2025
      Business Wire

      Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan

      Poxel eligible for royalties equaling 10% of all TWYMEEG® net sales for 20241 and a one-time sales-based payment of JPY 500 million (EUR 3.1 million2) Allocation of all revenues received to the...

      January 20 2025
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.022-7.457627118640.2950.30750.253701380.27633483DE
      40.090849.83534577390.18220.39850.16310812230.30007089DE
      120.02811.42857142860.2450.39850.1157177990.24469502DE
      26-0.356-56.59777424480.6290.7470.1154748170.32633607DE
      52-0.275-50.18248175180.5480.8980.1153769170.42790348DE
      156-3.927-93.54.24.20.1151951180.65703906DE
      260-10.307-97.419659735310.5811.160.1151671302.41274429DE

      POXEL - Frequently Asked Questions (FAQ)

      What is the current Poxel share price?
      The current share price of Poxel is 0.273 €
      How many Poxel shares are in issue?
      Poxel has 46,586,753 shares in issue
      What is the market cap of Poxel?
      The market capitalisation of Poxel is EUR 13.04M
      What is the 1 year trading range for Poxel share price?
      Poxel has traded in the range of 0.115 € to 0.898 € during the past year
      What is the PE ratio of Poxel?
      The price to earnings ratio of Poxel is -0.36
      What is the cash to sales ratio of Poxel?
      The cash to sales ratio of Poxel is 6.35
      What is the reporting currency for Poxel?
      Poxel reports financial results in EUR
      What is the latest annual turnover for Poxel?
      The latest annual turnover of Poxel is EUR 1.98M
      What is the latest annual profit for Poxel?
      The latest annual profit of Poxel is EUR -35.09M
      What is the registered address of Poxel?
      The registered address for Poxel is 259/261 AVENUE JEAN JAURES - IMMEUBLE LE SUNWAY, LYON, RHONE, 69007
      What is the Poxel website address?
      The website address for Poxel is www.poxelpharma.com
      Which industry sector does Poxel operate in?
      Poxel operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALCABCabasse SA
      0.77 €
      (67.39%)
      		93.29k
      ALEXPOne Experience
      0.496 €
      (64.24%)
      		2.54k
      VTRVitura
      5.80 €
      (62.92%)
      		2.37k
      DMSBSDiagnostic Medical Systems
      0.007 €
      (40.00%)
      		15.1k
      ALVERVergnet
      0.0009 €
      (28.57%)
      		23.09M
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		18.59M
      BAIOdyssey Acquisition SA
      0.1285 €
      (-49.80%)
      		834.05k
      ALALOAcheterLouerFR
      0.0148 €
      (-34.80%)
      		2.31M
      MLWEYWeya
      0.018 €
      (-33.33%)
      		52.31k
      MLCOTCoretech 5
      0.0335 €
      (-33.00%)
      		61k
      ATOAtos SE
      0.0021 €
      (0.00%)
      		1.12B
      ALVERVergnet
      0.0009 €
      (28.57%)
      		23.09M
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		18.59M
      ALHGLouis Hachette Group
      1.331 €
      (-2.90%)
      		11.49M
      BCPBanco Comercial Portugues SA
      0.5008 €
      (-1.14%)
      		10.67M

      Discussion

      View Full Feed
      igotthemojo igotthemojo 1 minute ago
      "As of December 31, 2023, there was $2,617,211 in loan interest"

      nope...there was $1.6 mil in outstanding LOANS (not interest)...

      "As of December 31, 2024, there was a preliminary and unaudited $304,545 in loan interest"

      correct...$304,545 in INTEREST acc
      KBLB
      lovethatgreen lovethatgreen 2 minutes ago
      Thia account is suspended until Nov 2027
      RITE
      cptbac cptbac 4 minutes ago
      Exactly.
      NWBO
      janice shell janice shell 6 minutes ago
      By the way, I just watched that video. What on earth presumably makes you believe I think this country is okay, and going in the right direction?

      I should have imagined that you'd understood from my many posts that I think we're headed to hell in a handbasket. Unlike you, I do not fe
      StocktonCA StocktonCA 9 minutes ago
      this bill is on the current Congress' calender to be discussed sometime before the end of Feb

      Shown Here:
      Introduced in Senate (03/28/2023)

      Setting Consumer Standards for Lithium-Ion Batteries Act

      This bill requires the Consumer Product Safety Comm
      TORVF
      Chachang1 Chachang1 12 minutes ago
      It's nearly March. This stock has a history of running hard in March. First the float gets soaked up cheap which we have been seeing happening. Next, the Company will put out press and other media. Watch for this as they have been silent. Then boom, a run. As Florida stated he ran this from down her
      RLTR
      StocktonCA StocktonCA 13 minutes ago
      Shown Here:
      Introduced in Senate (03/28/2023)

      Setting Consumer Standards for Lithium-Ion Batteries Act

      This bill requires the Consumer Product Safety Commission to issue a consumer product safety standard for rechargeable lithium-ion batteries used in micromobili
      KULR
      TightCoil TightCoil 17 minutes ago
      Remember Buffett's Famous Fannie Fumble -
      How he always wanted to own "The Lion's Share,"
      of FNMA...Aah, What Might Have Been - What
      Could Have Been....now gone...or is it?
      FNMA
      Chachang1 Chachang1 18 minutes ago
      Some guys in one of my groups were talking about a major partnership with Ecite that will put this worldwide. Supposedly a bigger player than Lucid.
      VAPR
      janice shell janice shell 24 minutes ago
      Looks to me like a lot of neo fascist, antisemitic claptrap, but hey, I guess I'm just too old to appreciate the return of Mussolini in the form of Orban.

      Nonetheless, I'm the one with the Ph.D., not you.
      timmins4 timmins4 25 minutes ago
      You are correct, Honore has no use for Trump.
      AGSS
      facts_matter14 facts_matter14 29 minutes ago
      No matter who wins the Super Bowl, POSRMX bag holders are still the losers, and we all know who the biggest one is after “borrowing” all those shares……

      Fly Eagles Fly

      Lie Maxine Li-e






      .



      SRMX
      thecrusher2011 thecrusher2011 32 minutes ago
      It's a very clear choice all over the world, globalism and the great reset.......vs. the great awakening. If you've read any Russian philosophy or heck Russian writing for that matter i.e. Dostoevsky. You're amazed at the brilliance of these people. Maybe that's why they're so good at chess. At any
      Dallas-Cowboys Dallas-Cowboys 40 minutes ago
      Jab that is a shame I'm sure I've told this before, Sprycell posted on the Tell board many times about TGLO in the spring of 2018. I remember on a Saturday coming to the TGLO board spending a lot of time reading back posts trying to do DD it was hard not a lot of info outside of the board. The feeli
      TGLO
      onehundredmph onehundredmph 43 minutes ago
      👍️😂😉
      CRGP
      arizona1 arizona1 49 minutes ago
      West Virginia, the most obese state, now can’t afford weight loss drugs
      https://www.wtrf.com/west-virginia/west-virginia-the-most-obese-state-now-cant-afford-weight-loss-drugs/

      West Virginia: Most fentanyl overdoses, most obese, most uneducated, most illiterate, worst infrastr
      janice shell janice shell 49 minutes ago
      I have not. But I can guarantee you I would be repelled by what Dugin stands for.
      janice shell janice shell 50 minutes ago
      What? I've never told anyone how to raise kids. As an only child, the only thing I know about children is what I know because I once was one.

      Though I admit I'm sometimes surprised by what many parents have evidently forgotten about that. For example, that if you get all huffy and st
      chereb19 chereb19 51 minutes ago
      The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
      Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
      RDGL
      newmedman newmedman 52 minutes ago
      I don't know, you're the self proclaimed "alpha male" so it would make better sense for you to be giving answers rather than asking questions, you pussy.

      https://www.mancamp.us/?gad_source=2&gclid=CjwKCAiAnpy9BhAkEiwA-P8N4hzVVHDLN-bLAo-mZtFaWOcQdp9Q29MU5qRm--Rnrn31nWpYRr4H8xoC_qoQAvD_
      thecrusher2011 thecrusher2011 52 minutes ago
      Just say you've never read the book either. It would save you a lot of embarrassment.

      Your Recent History

      EU
      POXEL
      Poxel
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads